Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Misonix/Focus Surgery take Sonoblate to Europe:

This article was originally published in Clinica

Executive Summary

Misonix is to distribute Focus Surgery's Sonoblate 500 high frequency ultrasound (HIFU) system in Europe and Russia for the treatment of prostate cancer and other prostate conditions. Farmingdale, New York-based Misonix has signed a two-year deal with Indianapolis, Indiana-based Focus Surgery, in which it holds a 20% stake. The arrangement will be renewable yearly depending on minimum purchases. The CE-marked device will be marketed by Misonix's new sales force. Misonix "will benefit not only from manufacturing the product but [will] also participate in the mark-up to the end customer upon final sale", said president and CEO Michael McManus.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel